These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6775418

  • 1. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T, Koller E, Doleschel W, Mayr WR.
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [Abstract] [Full Text] [Related]

  • 2. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T, Koller E, Doleschel W.
    Thromb Haemost; 1979 Oct 31; 42(3):832-7. PubMed ID: 505400
    [Abstract] [Full Text] [Related]

  • 3. In vitro characterization of various factor VIII concentrates.
    Yoshioka A, Shima M, Nishino M, Yoshikawa N, Fukui H.
    Arzneimittelforschung; 1987 Jul 31; 37(7):753-6. PubMed ID: 3118888
    [Abstract] [Full Text] [Related]

  • 4. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV, Griffin B, Pepper DS, Dickson AJ, McQuillan TA, Dickson IH, Foster PR.
    Thromb Haemost; 1981 Oct 31; 46(3):597-601. PubMed ID: 6797090
    [Abstract] [Full Text] [Related]

  • 5. [Comparative protein chemistry studies on Factor VIII concentrates].
    Kienast K, Trobisch H.
    Arzneimittelforschung; 1984 Oct 31; 34(8):895-900. PubMed ID: 6437415
    [Abstract] [Full Text] [Related]

  • 6. [Factor VIII activity and factor VIII associated antigen in newborns (author's transl)].
    Muntean W, Belohradsky BH, Klose HJ, Riegel K.
    Klin Padiatr; 1977 Nov 31; 189(6):412-413, 6. PubMed ID: 74433
    [Abstract] [Full Text] [Related]

  • 7. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE, Smith JK.
    Thromb Haemost; 1982 Aug 24; 48(1):46-8. PubMed ID: 6813994
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP.
    Thromb Haemost; 1981 Aug 28; 46(2):479-84. PubMed ID: 6795738
    [Abstract] [Full Text] [Related]

  • 9. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC, Pepper DS, Griffin B.
    Thromb Haemost; 1981 Aug 28; 46(2):543-6. PubMed ID: 6795742
    [Abstract] [Full Text] [Related]

  • 10. [In vitro study of different factor VIII concentrates. Biochemical and structural characteristics of factor VIII (author's transl)].
    Massot M, Vidal A, Más J, Laguna V, Vilanova X.
    Sangre (Barc); 1982 Aug 28; 27(1):39-52. PubMed ID: 6808678
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study of concentrated blood derivatives of factor VIII].
    Baklaja R, Miletić V, Stajić M, Cvetković V, Grozdanić V.
    Bilt Hematol Transfuz; 1984 Aug 28; 12(2):91-103. PubMed ID: 6441567
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of the factor VIII protein and Factor XIII in various factor VIII concentrates.
    Nilsson IM, Holmberg L, Stenberg P, Henriksson P.
    Scand J Haematol; 1980 Apr 28; 24(4):340-9. PubMed ID: 6774412
    [Abstract] [Full Text] [Related]

  • 13. Factor VIII-related activities in therapeutic concentrates.
    Barrowcliffe TW, Kemball-Cook G, Morris G, Holt JC, Furlong RA, Peake IR.
    J Lab Clin Med; 1981 Mar 28; 97(3):429-38. PubMed ID: 6780643
    [Abstract] [Full Text] [Related]

  • 14. [Application if different techniques to the diagnosis of von Willebrand's disease (author's transl)].
    Solana JM, Rocha E, Arrizabalaga B, López A, Febres R, Fernández J.
    Sangre (Barc); 1981 Mar 28; 26(6):1156-63. PubMed ID: 6805084
    [No Abstract] [Full Text] [Related]

  • 15. [Bovine factor VIII. Antigens and biological activities (author's transl)].
    Casillas G, Simonetti C, Pavlovsky A.
    Sangre (Barc); 1977 Mar 28; 22(6):238-48. PubMed ID: 601671
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.
    Thromb Haemost; 2007 Jun 28; 97(6):922-30. PubMed ID: 17549293
    [Abstract] [Full Text] [Related]

  • 17. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
    Morfini M, Longo G, Matucci M, Vannini S, Messori A, Filimberti E, Duminuco M, Avanzi G, Rossi-Ferrini P.
    Ric Clin Lab; 1984 Jun 28; 14(4):681-91. PubMed ID: 6441235
    [Abstract] [Full Text] [Related]

  • 18. Native analysis of plasma-derived clotting factor VIII concentrates: "sponge effect" and contaminants.
    Blasi B, D'Amici GM, D'Alessandro A, Zolla L.
    Electrophoresis; 2012 Apr 28; 33(8):1292-8. PubMed ID: 22589109
    [Abstract] [Full Text] [Related]

  • 19. [Chromatographic behaviour of factor VIII molecule on sepharose 4 B column (author's transl)].
    Rocha E, Solana JM, Fernández J, Narvaiza MJ, Cuesta B, Hernández M.
    Sangre (Barc); 1979 Apr 28; 24(5):567-78. PubMed ID: 538551
    [No Abstract] [Full Text] [Related]

  • 20. Factor VIII and factor IX Sub-Committee. Recommendations for the assay of high-purity factor VIII concentrates.
    Barrowcliffe TW.
    Thromb Haemost; 1993 Nov 15; 70(5):876-7. PubMed ID: 8128450
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.